首页> 外文OA文献 >The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibition

【2h】

The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibition

机译：SLCO1B1和ABCB1基因型对Simvastatin的药代动力学的影响，关于CYP3A4抑制作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Fen Jiang; Jong-Yeol Choi; Ju-Hyun Lee; Sunae Ryu; Ze-Won Park; Jong-Gu Lee; Han-Sung Na; Seok-Yong Lee; Woo-Yong Oh; Myeon-Woo Chung; Seung-Eun Choi;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibition [J] . Jiang Fen, Choi Jong-Yeol, Lee Ju-Hyun, Pharmacogenomics . 2017,第5期

机译：SLCO1B1和ABCB1基因型对辛伐他汀的药代动力学的影响，关于CYP3A4抑制作用
2. Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms. [J] . Bernsdorf A, Giessmann T, Modess C, British Journal of Clinical Pharmacology . 2006,第4期

机译：辛伐他汀不影响肠道P-糖蛋白和MPR2，以及在长期用药后替尼洛尔在ABCB1，ABCC2和SLCO1B1基因多态性基因型健康受试者中的分布。
3. Simvastatin pharmacokinetics in healthy Chinese subjects and its relations with CYP2C9, CYP3A5, ABCB1, ABCG2 and SLCO1B1 polymorphisms. [J] . Quan Zhou, Zou-Rong Ruan, Bo Jiang, Die Pharmazie . 2013,第2期

机译：辛伐他汀在中国健康人群中的药代动力学及其与CYP2C9，CYP3A5，ABCB1，ABCG2和SLCO1B1多态性的关系。
4. Pharmacokinetic model for the inhibition of simvastatin metabolism by itraconazole [C] . Lohitnavy Manupat, Methaneethorn Janthima, Chiang-Ngernthanyakool Rangsimaporn, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2015

机译：伊曲康唑抑制辛伐他汀代谢的药代动力学模型
5. Contribution of itraconazole and its metabolites to in vivo CYP3A4 inhibition. [D] . Templeton, Ian Edward. 2009

机译：伊曲康唑及其代谢物对体内CYP3A4抑制的作用。
6. Simvastatin does not influence the intestinal P-glycoprotein and MPR2 and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1 ABCC2 and SLCO1B1 polymorphisms [O] . Annika Bernsdorf, Thomas Giessmann, Christiane Modess, 2006

机译：辛伐他汀不影响ABCB1ABCC2和SLCO1B1基因多态性基因型健康受试者的慢性用药后肠道P-糖蛋白和MPR2以及他尼洛尔的处置
7. Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms [O] . Bernsdorf, Annika, Giessmann, Thomas, Modess, Christiane, 2006

机译：辛伐他汀对ABCB1，ABCC2和SLCO1B1基因多态性基因型健康受试者的慢性用药后肠内P-糖蛋白和MPR2以及他尼洛尔的处置没有影响

The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibition

著录项

引文网络

相似文献

相关主题

期刊订阅